The investment team seeks to invest in companies with franchise characteristics that are benefiting from an accelerating profit cycle and are trading at a discount to private market value.
As of 30 June 2024 | QTD | YTD | 1 Yr | 3 Yr | 5 Yr | 10 Yr | Inception |
---|---|---|---|---|---|---|---|
Advisor Class: APDSX | -4.40 | 4.60 | 5.19 | -9.38 | 4.91 | 9.04 | 8.95 |
Russell 2000® Growth Index | -2.92 | 4.44 | 9.14 | -4.86 | 6.17 | 7.39 | 7.55 |
Russell 2000® Index | -3.28 | 1.73 | 10.06 | -2.58 | 6.94 | 7.00 | 8.76 |
As of 30 June 2024 | QTD | YTD | 1 Yr | 3 Yr | 5 Yr | 10 Yr | Inception |
---|---|---|---|---|---|---|---|
Advisor Class: APDSX | -4.40 | 4.60 | 5.19 | -9.38 | 4.91 | 9.04 | 8.95 |
Russell 2000® Growth Index | -2.92 | 4.44 | 9.14 | -4.86 | 6.17 | 7.39 | 7.55 |
Russell 2000® Index | -3.28 | 1.73 | 10.06 | -2.58 | 6.94 | 7.00 | 8.76 |
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Advisor Class: APDSX | 40.33 | 61.19 | -8.77 | -29.36 | 9.51 |
Russell 2000® Growth Index | 28.48 | 34.63 | 2.83 | -26.36 | 18.66 |
Russell 2000® Index | 25.52 | 19.96 | 14.82 | -20.44 | 16.93 |
Semi-Annual Report 31 March 2024 | 1.09% |
---|---|
Prospectus 30 September 2023 | 1.07% |
See prospectus for further details. Semi-Annual Report Figure(s): Unaudited, annualized for the six-month period.
Top 10 Holdings (% of total portfolio as of 30 June 2024) |
|
---|---|
Halozyme Therapeutics Inc (Health Care) | 5.8 |
Guidewire Software Inc (Information Technology) | 5.2 |
Lattice Semiconductor Corp (Information Technology) | 4.7 |
Ascendis Pharma A/S (Health Care) | 4.5 |
Argenx SE (Health Care) | 4.4 |
SPX Technologies Inc (Industrials) | 3.7 |
Twist Bioscience Corp (Health Care) | 3.2 |
Tyler Technologies Inc (Information Technology) | 3.0 |
MACOM Technology Solutions Holdings Inc (Information Technology) | 2.9 |
Novanta Inc (Information Technology) | 2.8 |
Total | 40.3% |
Portfolio Statistics (as of 30 June 2024) |
|
---|---|
Median Market Cap (Billions) | $6.8 |
Weighted Avg. Market Cap (Billions) | $8.5 |
Weighted Harmonic Avg. P/E (FY1) | 32.2X |
Weighted Harmonic Avg. P/E (FY2) | 27.8X |
Weighted Avg. Hist. 3 Yr Sales Growth | 33.0% |
Weighted Avg. LT Debt/Capital | 30.9% |
Active Share | 91.9% |
Annual Turnover | 30.1% |
Number of Securities | 61 |
Cash (% of total portfolio) | 1.8% |
Market Cap Distribution (% of portfolio securities as of 30 June 2024) $ in billions |
|
---|---|
5.9+ | 71.9 |
4.1–5.9 | 8.3 |
2.9–4.1 | 9.5 |
1.8–2.9 | 6.7 |
0.0–1.8 | 3.6 |
TOTAL | 100.0% |
Sector Diversification (% of portfolio securities as of 30 June 2024) |
|
---|---|
Communication Services | — |
Consumer Discretionary | 10.2 |
Consumer Staples | 2.4 |
Energy | — |
Financials | 2.0 |
Health Care | 33.5 |
Industrials | 12.5 |
Information Technology | 39.4 |
Materials | — |
Real Estate | — |
Utilities | — |
Other | — |
Total | 100.0% |